Results: 927 news stories
Max and Minnie Tomerlin Voelcker Fund grants UT Health San Antonio $1.25 million to support research from early career investigators
The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been awarded $1.25 million by the Max and Minnie Tomerlin Voelcker Fund to support research projects being conducted by the institution’s early career investigators. Voelcker Fund Young Investigator Awards The Voelcker Fund Young Investigator Award will fund each recipient’s […]
Owens Medical Research Foundation awards UT Health San Antonio investigators $1.5 million to advance Alzheimer’s and cancer research
The William and Ella Owens Medical Research Foundation recently awarded $1.5 million to The University of Texas Health Science Center at San Antonio (UT Health San Antonio) for research projects that address pancreatic cancer, Alzheimer’s disease and childhood cancers. This year, the foundation will fund $250,000 each to six research projects from UT Health […]
Drug Target Review: Why PARP inhibitors fail: key role of the CST complex in BRCA1-deficient cancers
Drug Target Review: Why PARP inhibitors fail: key role of the CST complex in BRCA1-deficient cancers
Science Magazine: Innovative Urine-Based Tumor DNA Test Promises Personalized Bladder Cancer Therapy
Science Magazine: Innovative Urine-Based Tumor DNA Test Promises Personalized Bladder Cancer Therapy
Medical Xpress: Urine-based tumor DNA test may help personalize bladder cancer treatment
Medical Xpress: Urine-based tumor DNA test may help personalize bladder cancer treatment
MSN.com: Urine-based DNA test predicts bladder cancer recurrence after immunotherapy
MSN.com: Urine-based DNA test predicts bladder cancer recurrence after immunotherapy
Bioengineer.org: Innovative Urine-Based Tumor DNA Test Promises Personalized Bladder Cancer Therapy
Bioengineer.org: Innovative Urine-Based Tumor DNA Test Promises Personalized Bladder Cancer Therapy
News-Medical: Urine-based DNA test predicts bladder cancer recurrence after immunotherapy
News-Medical: Urine-based DNA test predicts bladder cancer recurrence after immunotherapy
WOAI TV (NEWS4SA): UT Health San Antonio receives $3.4M for cancer research and HPV vaccination efforts
WOAI TV (NEWS4SA): UT Health San Antonio receives $3.4M for cancer research and HPV vaccination efforts
New urine-based tumor DNA test may help personalize bladder cancer treatment
In a multi-institutional study published in Science Direct, researchers revealed that testing urine-based tumor DNA (utDNA) can help predict which bladder cancer patients are at higher risk for recurrence after treatment.
Healthcare IT News: HIMSSCast: How an MD/MS in AI dual degree could change health IT leadership
Healthcare IT News: HIMSSCast: How an MD/MS in AI dual degree could change health IT leadership
PipelineReview.com: Cirius Therapeutics Announces Positive Data for MPC Inhibitor 0602K Alone and in Combination with Tirzepatide
PipelineReview.com: Cirius Therapeutics Announces Positive Data for MPC Inhibitor 0602K Alone and in Combination with Tirzepatide
FirstWord Pharma: Cirius Therapeutics Announces Positive Data for MPC Inhibitor 0602K Alone and in Combination with Tirzepatide
FirstWord Pharma: Cirius Therapeutics Announces Positive Data for MPC Inhibitor 0602K Alone and in Combination with Tirzepatide
CancerNetwork: Rhenium Obisbemeda Shows No DLTs and Improves Survival in Recurrent Glioma
CancerNetwork: Rhenium Obisbemeda Shows No DLTs and Improves Survival in Recurrent Glioma
Archynetys.com: BRCA1 & Cancer Resistance — New Study Findings
Archynetys.com: BRCA1 & Cancer Resistance — New Study Findings
Bioengineer.org: UT Health San Antonio Scientists Uncover Key Mechanisms Behind Cancer Drug Resistance
Bioengineer.org: UT Health San Antonio Scientists Uncover Key Mechanisms Behind Cancer Drug Resistance
Science Magazine: UT Health San Antonio Scientists Uncover Key Mechanisms Behind Cancer Drug Resistance
Science Magazine: UT Health San Antonio Scientists Uncover Key Mechanisms Behind Cancer Drug Resistance
Technology Networks: The Role of the CST Complex in Cancer Drug Resistance
Technology Networks: The Role of the CST Complex in Cancer Drug Resistance
Texas Public Radio: A non-opioid painkiller has hit the market, and a San Antonio doctor calls it a game-changer
Texas Public Radio: A non-opioid painkiller has hit the market, and a San Antonio doctor calls it a game-changer
Texas Public Radio (KSTX): San Antonio researcher finds that cholesterol levels may predict Alzheimer’s risk
Texas Public Radio (KSTX): San Antonio researcher finds that cholesterol levels may predict Alzheimer’s risk